Dr. Matthew Price is the Director of the Cardiac Catheterization Laboratory at Scripps Clinic and Assistant Professor at the Scripps Translational Science Institute in La Jolla, California. He graduated from Cornell University with Distinction in All Subjects. He earned his MD at the University of California, Los Angeles (UCLA) School of Medicine and completed his internship and residency in Internal Medicine at the UCLA Center for Health Sciences. He subsequently completed a fellowship in Cardiovascular Diseases at Cedars-Sinai Medical Center in Los Angeles, where he served as Chief Fellow. Dr Price completed his training in Interventional Cardiology at Scripps Clinic.
Dr Price is certified by the American Board of Internal Medicine in Internal Medicine, Cardiovascular Disease, and Interventional Cardiology. His clinical and research focus includes high-risk percutaneous coronary intervention (PCI), interventional approaches to congenital and structural heart disease, and antiplatelet therapy. Dr Price is involved in the leadership of several clinical trials examining the effectiveness of antiplatelet therapy during, and is the principal investigator of GRAVITAS, a randomized clinical trial that is examining the safety and efficacy of individualized thienopyrdine therapy after PCI. He serves as an ad hoc reviewer for several professional journals, including the American Heart Journal, the American Journal of Cardiology, Circulation, and the Journal of the American College of Cardiology. |
Join Our Mailing List
2011 Congress Details
2011 Online CME Activity
Useful Links
Recommend This Site 
